Osaic Holdings
XERS icon

Osaic Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

Osaic Holdings’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Sell
45,496
-9,260
-17% -$59.1K ﹤0.01% 3953
2026
Q1 		$318K Buy
54,756
+2,471
+5% +$16.4K ﹤0.01% 3771
2025
Q4 		$410K Buy
52,285
+11,934
+30% +$93.9K ﹤0.01% 3512
2025
Q3 		$325K Sell
40,351
-2,358
-6% -$15.7K ﹤0.01% 3790
2025
Q2 		$199K Buy
42,709
+3,774
+10% +$17.3K ﹤0.01% 3945
2025
Q1 		$214K Sell
38,935
-4,886
-11% -$19.7K ﹤0.01% 3566
2024
Q4 		$149K Buy
43,821
+867
+2% +$2.79K ﹤0.01% 3867
2024
Q3 		$122K Buy
42,954
+5,454
+15% +$14K ﹤0.01% 4069
2024
Q2 		$84.4K Buy
37,500
+11,927
+47% +$24K ﹤0.01% 4271
2024
Q1 		$56.5K Buy
25,573
+7,150
+39% +$18.5K ﹤0.01% 4661
2023
Q4 		$43.3K Sell
18,423
-3,611
-16% -$6.66K ﹤0.01% 4999
2023
Q3 		$41K Buy
22,034
+5,627
+34% +$12.9K ﹤0.01% 5123
2023
Q2 		$43K Buy
16,407
+5,500
+50% +$14K ﹤0.01% 5033
2023
Q1 		$17.8K Hold
10,907
– – ﹤0.01% 5635
2022
Q4 		$15K Sell
10,907
-15,425
-59% -$21.8K ﹤0.01% 5751
2022
Q3 		$41K Sell
26,332
-400
-1% -$662 ﹤0.01% 5052
2022
Q2 		$42K Buy
26,732
+22,632
+552% +$47.8K ﹤0.01% 5091
2022
Q1 		$11K Sell
4,100
-34,673
-89% -$84.7K ﹤0.01% 6094
2021
Q4 		$113K Buy
38,773
+10,697
+38% +$23.1K ﹤0.01% 4496
2021
Q3 		$69K Sell
28,076
-3,559
-11% -$10.3K ﹤0.01% 4854
2021
Q2 		$129K Buy
31,635
+7,515
+31% +$28.7K ﹤0.01% 4259
2021
Q1 		$109K Buy
24,120
+16,350
+210% +$88.2K ﹤0.01% 4271
2020
Q4 		$39K Buy
7,770
+4,000
+106% +$20K ﹤0.01% 4743
2020
Q3 		$22K Buy
3,770
+200
+6% +$800 ﹤0.01% 4865
2020
Q2 		$9K Buy
+3,570
New +$12.4K ﹤0.01% 5244

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Osaic Holdings's XERS Position: Q2 2026 in Review

Osaic Holdings reduced its Xeris Biopharma Holdings (XERS) stake by 17% in Q2 2026, selling an estimated $59.1K and leaving 45,496 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #3953.

Osaic Holdings first reported a position in XERS in Q2 2020 and has held it in 25 quarters since. The position peaked at $410K in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Osaic Holdings held 45,496 shares of Xeris Biopharma Holdings worth $360K as of Q2 2026.
  • Osaic Holdings sold 9,260 Xeris Biopharma Holdings shares in Q2 2026, an estimated $59.1K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3953 holding.
  • Osaic Holdings first reported a position in Xeris Biopharma Holdings in Q2 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Xeris Biopharma Holdings position peaked at $410K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.